Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTHFD2P3 is officially annotated as a pseudogene, which means it is a segment of DNA similar to the functional methylenetetrahydrofolate dehydrogenase 2 gene but is typically considered non-coding and non-functional. Pseudogenes generally do not produce active protein products and lack direct biological or clinical relevance. Their presence may be noted in genomic studies, but MTHFD2P3 itself is not an enzyme, receptor, or transporter, nor is it established as a therapeutic target. Information on MTHFD2P3 is limited, and it should not be confused with MTHFD2, which is an active mitochondrial enzyme involved in folate metabolism and cell proliferation, and has emerging implications in cancer biology[2][4].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylenetetrahydrofolate dehydrogenase 2, methenyltetrahydrofolate cyclohydrolase pseudogene 3 (MTHFD2P3).